The immune and inflammatory enhancements seen with CMS1 and CMS4 CRC are mirrored in the increased immune cell recruitment, immune-related gene expression, and enhancement of immune and inflammatory pathways shown with high MSLN expression (Figs. 4 and 5). This evidence concerns the gene MSLN and colorectal carcinoma.